Of note, while we previously demonstrated that MKT-077, a mortalin inhibitor, can suppress MTC xenografts in mice without causing serious toxicity [14], there has been effort to improve the efficacy and bioavailability of this compound [29]. This evidence concerns the gene HSPA9 and medullary thyroid gland carcinoma.